BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Clindamycin

An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.

298+ PubMed studies analyzed · 37 RCTs · Evidence Score: 48.7

Research Domains

Clindamycin has been studied across 13 research domains including ✨ Skin & Hair, 🦠 Gut & Microbiome, 🦴 Bone & Joint, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is ✨ Skin & Hair with 8% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Clindamycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Fenoterol
2 shared targets
Aprindine
2 shared targets
Chlorpropamide
2 shared targets
Alprenolol
2 shared targets
Dihydroergocornine
2 shared targets
Rifamycins
2 shared targets
Rifamycins
2 shared targets
Metformin
2 shared targets
Venlafaxine
2 shared targets
Thiethylperazine
2 shared targets
Loading evidence profile...

This evidence profile for Clindamycin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.